L K Shawver

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

Cherrington, R A Blake, S. Hubbard, 2000, Cancer research.

Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases.

G. Mcmahon, L. Sun, C. Tang, 1999, Journal of medicinal chemistry.

A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines.

P. Toy, L K Shawver, L. Shawver, 1991, Cancer research.

New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.

J. Cherrington, L K Shawver, L M Strawn, 2000, Advances in cancer research.